Literature DB >> 15033446

An anti-proliferative gene BTG1 regulates angiogenesis in vitro.

Kenji Iwai1, Ken-ichi Hirata, Tatsuro Ishida, Shigeto Takeuchi, Tetsuaki Hirase, Yoshiyuki Rikitake, Yoko Kojima, Nobutaka Inoue, Seinosuke Kawashima, Mitsuhiro Yokoyama.   

Abstract

B-cell translocation gene 1 (BTG1) is a member of the anti-proliferative gene family that regulates cell growth and differentiation. To clarify the role of BTG1 in angiogenesis, we examined the regulation of BTG1 expression in cultured endothelial cells and characterized its function in in vitro models of angiogenesis. BTG1 mRNA was abundantly expressed in quiescent endothelial cells. Addition of serum and angiogenic growth factors decreased BTG1 mRNA levels in endothelial cells. In contrast, BTG1 mRNA was up-regulated in tube-forming endothelial cells on Matrigel. This up-regulation was partially blocked by neutralizing antibody against transforming growth factor-beta (TGF-beta), and TGF-beta increased BTG1 mRNA levels. Inhibition of endogenous BTG1 by overexpression of antisense BTG1 resulted in inhibited network formation, and overexpression of sense BTG1 augmented tube formation in these cell lines. BTG1-overexpressing endothelial cells displayed increased cell migration. These findings suggest that BTG1 may play an important role in the process of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033446     DOI: 10.1016/j.bbrc.2004.02.095

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Consistent across-tissue signatures of differential gene expression in Crohn's disease.

Authors:  Austin L Hughes
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

2.  Molecular cloning, sequence analysis, and cadmium stress-rated expression changes of BTG1 in freshwater pearl mussel (Hyriopsis schlegelii).

Authors:  Kou Peng; Cheng-Yuan Wang; Jun-Hua Wang; Jun-Qing Sheng; Jian-Wu Shi; Jian Li; Yi-Jiang Hong
Journal:  Dongwuxue Yanjiu       Date:  2014-09

3.  The ETS factor TEL2 is a hematopoietic oncoprotein.

Authors:  Cintia Carella; Mark Potter; Jacqueline Bonten; Jerold E Rehg; Geoffrey Neale; Gerard C Grosveld
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

Review 4.  The Philadelphia chromosome in leukemogenesis.

Authors:  Zhi-Jie Kang; Yu-Fei Liu; Ling-Zhi Xu; Zi-Jie Long; Dan Huang; Ya Yang; Bing Liu; Jiu-Xing Feng; Yu-Jia Pan; Jin-Song Yan; Quentin Liu
Journal:  Chin J Cancer       Date:  2016-05-27

5.  Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.

Authors:  Jun Shao; Yunbin Zhang; Guangming Fan; Yu Xin; Yong Yao
Journal:  BMC Med Genomics       Date:  2019-10-15       Impact factor: 3.063

6.  BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial-Mesenchymal Transition.

Authors:  Shuang Zhao; Hang Xue; Chang-Lai Hao; Hua-Mao Jiang; Hua-Chuan Zheng
Journal:  Front Oncol       Date:  2020-11-27       Impact factor: 6.244

7.  Btg1 is Required to Maintain the Pool of Stem and Progenitor Cells of the Dentate Gyrus and Subventricular Zone.

Authors:  Stefano Farioli-Vecchioli; Laura Micheli; Daniele Saraulli; Manuela Ceccarelli; Sara Cannas; Raffaella Scardigli; Luca Leonardi; Irene Cinà; Marco Costanzi; Maria Teresa Ciotti; Pedro Moreira; Jean-Pierre Rouault; Vincenzo Cestari; Felice Tirone
Journal:  Front Neurosci       Date:  2012-08-30       Impact factor: 4.677

8.  Independent component analysis of Alzheimer's DNA microarray gene expression data.

Authors:  Wei Kong; Xiaoyang Mou; Qingzhong Liu; Zhongxue Chen; Charles R Vanderburg; Jack T Rogers; Xudong Huang
Journal:  Mol Neurodegener       Date:  2009-01-28       Impact factor: 14.195

9.  Genomic analysis of human lung fibroblasts exposed to vanadium pentoxide to identify candidate genes for occupational bronchitis.

Authors:  Jennifer L Ingram; Aurita Antao-Menezes; Elizabeth A Turpin; Duncan G Wallace; James B Mangum; Linda J Pluta; Russell S Thomas; James C Bonner
Journal:  Respir Res       Date:  2007-04-25

10.  BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.

Authors:  Shuang Zhao; Shu-Rui Chen; Xue-Feng Yang; Dao-Fu Shen; Yasuo Takano; Rong-Jian Su; Hua-Chuan Zheng
Journal:  Oncotarget       Date:  2017-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.